Digital Tools and Strategies for Engaging Patients in Cancer Clinical Trials

Area of Science:

• Health Communication
• Behavioral Science
• Patient-Centered Design

Background:

• Digital tools are increasingly vital for patient engagement in cancer clinical trials, influencing recruitment, education, and electronic consent processes.
• The integration of these tools into clinical research workflows highlights their impact on patient perception, interpretation, and decision-making, especially under emotional and cognitive stress.

Purpose of the Study:

• To conduct a narrative mini-review of current digital tools used in cancer clinical trials.
• To identify challenges related to patient access and experience with these digital tools.
• To synthesize evidence-based design strategies for enhancing patient engagement and decision-making.

Main Methods:

• Review of current digital approaches including websites, mobile applications, social media, patient portals, e-consent platforms, and AI-driven tools.
• Synthesis of research from health communication, behavioral science, and patient-centered design.
• Analysis of challenges and evidence-based design strategies for digital patient engagement.

Main Results:

• Identified key challenges in patient access and experience with digital tools in cancer clinical trials.
• Synthesized evidence-based design strategies to support patient decision-making, reduce burdens, and build trust.
• Highlighted the importance of complementing, not replacing, human interaction through digital tools.

Conclusions:

• Future directions emphasize theory-informed, co-designed digital communication strategies for meaningful participation in cancer clinical research.
• Implementation and evaluation should assess patient understanding, decisional confidence, retention, and equity alongside enrollment metrics.
• Optimizing digital tools requires a focus on patient-centered design to support informed decision-making and engagement.